Zimmer Biomet reports positive outcomes data for Trabecular Metal Cups

Pharmaceutical Company Product News

Zimmer Biomet has announced that its Trabecular Metal Cups have demonstrated the benefits they can offer for revision hip arthroplasty patients in a new study.

Data from a new report from the National Joint Registry (NJR) indicated that the company's Trabecular Metal Cups were associated with lower infection rates and a significant reduction in subsequent hip revision rates among more than 9,500 patients.

“Zimmer Biomet's Trabecular Metal Cups have demonstrated positive outcomes in more than 9,500 patients undergoing revision hip arthroplasty.“

The company's Trabecular Metal is a highly porous biomaterial made from elemental tantalum, with structural, functional and physiological properties similar to bone. It features a 100 percent open, engineered and interconnected pore structure to support bony ingrowth and vascularisation.

Trabecular Metal Cups used in revision total hip arthroplasty were 21 percent less likely to be re-revised due to infection, rising to 35 percent for high-risk patients with a first revision indication of infection.

Dan Williamson, Zimmer Biomet's president of joint reconstruction, said: "The NJR report reinforces their value in significantly reducing hip revision rates in a large clinical patient population and yielding better outcomes in comparison to traditional non-Trabecular Metal implants."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Pharmaceutical
Return to news